Literature DB >> 7929309

The murine urokinase-type plasminogen activator receptor gene.

T T Suh1, C Nerlov, K Danø, J L Degen.   

Abstract

The murine urokinase-type plasminogen activator receptor (uPAR) gene has been isolated and its complete nucleotide sequence established. The gene is organized into seven exons comprising 9.5% of the 13,207-base pair region that spans the interval between the transcription initiation and polyadenylation sites. The region upstream of the transcription initiation site lacks TATA- or CCAAT-like elements but is flanked by a G+C-rich region, which contains a number of potential regulatory elements including Sp1 and AP1 binding motifs. The close association of both Sp1 and AP1 sites within the proximal promoter region is consistent with the observation that the murine uPAR gene is inducible by phorbol esters. The major functional domains of the encoded protein, including the signal peptide, three cysteine-rich internal repeats, and the glycolipid anchor attachment motif, are encoded by separate exons. Based on the organization of the murine uPAR gene and the distribution of protein domains within the exons in the Ly-6 family of genes, it appears that the uPAR gene evolved secondarily to two internal duplication events within a Ly-6-like ancestral gene. The cloned and sequenced murine uPAR gene will be a valuable tool in understanding the regulation and biological roles of uPAR in that it will permit detailed studies of gene expression and uPAR-dependent processes in vitro, as well as the generation of both gain-of-function and loss-of-function mutants in transgenic mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929309

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells.

Authors:  A H Ree; K Bjørnland; N Brünner; H T Johansen; K B Pedersen; A O Aasen; O Fodstad
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

2.  uPAR isoform 2 forms a dimer and induces severe kidney disease in mice.

Authors:  Changli Wei; Jing Li; Brian D Adair; Ke Zhu; Jian Cai; Michael Merchant; Beata Samelko; Zhongji Liao; Kwi Hye Koh; Nicholas J Tardi; Ranadheer R Dande; Shuangxin Liu; Jianchao Ma; Salvatore Dibartolo; Stefan Hägele; Vasil Peev; Salim S Hayek; David J Cimbaluk; Melissa Tracy; Jon Klein; Sanja Sever; Sanford J Shattil; M Amin Arnaout; Jochen Reiser
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

3.  Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice.

Authors:  Dominique Cathelin; Sandrine Placier; Michael Ploug; Marie-Christine Verpont; Sophie Vandermeersch; Yosu Luque; Alexandre Hertig; Eric Rondeau; Laurent Mesnard
Journal:  J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 10.121

4.  Genomic organization and expression of mouse thymic shared antigen-1 (TSA-1): evidence for a processed pseudogene.

Authors:  B J Classon; L Coverdale
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

Review 5.  suPAR: An Inflammatory Mediator for Kidneys.

Authors:  Yashwanth Reddy Sudhini; Changli Wei; Jochen Reiser
Journal:  Kidney Dis (Basel)       Date:  2022-06-08

6.  Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction.

Authors:  Elizabeth M Powell; Daniel B Campbell; Gregg D Stanwood; Caleb Davis; Jeffrey L Noebels; Pat Levitt
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

7.  Generation and characterization of urokinase receptor-deficient mice.

Authors:  M Dewerchin; A V Nuffelen; G Wallays; A Bouché; L Moons; P Carmeliet; R C Mulligan; D Collen
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

8.  Olfactory imprinting of amino acids in lacustrine sockeye salmon.

Authors:  Yuzo Yamamoto; Hiroshi Hino; Hiroshi Ueda
Journal:  PLoS One       Date:  2010-01-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.